About Imgenex India
Imgenex India is a Healthcare company based in Bhubaneswar (India) founded in 2004 by Sujay Singh. Antibodies and reagents are manufactured, with custom development services provided. Imgenex India has raised $297.15 thousand across 3 funding rounds from investors including Department of Biotechnology and CliniSciences. The company has 31 employees. Imgenex India was last valued at $317.62 thousand in January 2007. Its chief executive, as recorded, is Sujay Singh. Its Indian entity Imgenex India Private Limited reported revenue of ₹4.32 Cr. Imgenex India offers products and services including Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Life Sciences.
Company details
Imgenex India is an antibody and reagent developing company providing custom services in antibody development, recombinant protein production, and stable cell line development. It is also carrying out research projects in the areas of osteoporosis, cancer, and stem cells and inflammatory diseases either independently or in collaboration with national and international institutions. Its projects include developing a peptide-based therapy for osteoporosis in collaboration with Institute of Life Sciences (ILS), developing high expression plasmid vectors for production of biosimilar Herceptin and other recombinant proteins and bioprocess development for production of biosimilar Trastuzumab in phase II.
- Headquarters Bhubaneswar, India
- Employees 31
- Founders Sujay Singh
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website imgenexindia.com
- Social X
- Legal Name Imgenex India Private Limited
- Date of Incorporation 04 Jun, 2004
- Jurisdiction Bhubaneswar, Odisha, India
- Annual Revenue₹4.32 Cr
FY 2025 · +8% YoY
- Net Profit₹19.8 Lakh
FY 2025 · 5% margin
- EBITDA₹99.6 Lakh
FY 2025 · 23% margin
- Total Equity Funding$297.15K (USD)
in 3 rounds
- InvestorsDepartment of Biotechnology
& 1 more
- Employee Count31
Associated legal entities of Imgenex India
Imgenex India operates through Imgenex India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Imgenex India Private Limited CIN U24239OR2004PTC007628 | Active | 04 Jun 2004 | Bhubaneswar, Odisha | ₹4.3 Cr | 31 | 4 | View details |
Products & Services of Imgenex India
Imgenex India offers a comprehensive portfolio of products and services, including Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening.
Antibodies for therapeutic and diagnostic applications.
Development of cell lines for protein production and assays.
Tailored antibody production for research needs.
Large-scale purification of proteins using various systems.
Services to identify compounds modulating biomolecular pathways.
Funding Insights of Imgenex India
Imgenex India has successfully raised a total of $297.15K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $297,145
- Total Rounds 3
- First Round $297,145
(Jan 2007)
- Investors Count 2
All 3 funding rounds of Imgenex India with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2010 | Grant | – | – | ||
| Jun 2007 | Grant | – | – | ||
| Jan 2007 | $297,145 | Seed | $317,616 | CliniSciences | – |
Last known valuation $317,616 (Jan 2007). 2 investors in total: 2 institutional.
Investors in Imgenex India
Imgenex India has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Department of Biotechnology and CliniSciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
Provides reagents and instruments for scientific research in biology fields. | 1980 | clinisciences.com | Nanterre, France |
Investor details for Imgenex India
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Imgenex India Private Limited (Imgenex India)
Imgenex India Private Limited is the primary company behind Imgenex India. The board of Imgenex India Private Limited currently have 4 directors; the longest-serving is Sujay Kumar Singh, appointed in 2004. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sujay Kumar Singh DIN 00616056 | Director | 04 Jun 2004 | 22 yrs 4 mo | Imgenex India Private Limited |
| Gita Singh DIN 03625506 | Director | 02 Jan 2012 | 14 yrs 9 mo | Imgenex India Private Limited |
| Subrat Kumar Kar DIN 06855597 | Director | 27 Feb 2015 | 11 yrs 7 mo | Imgenex India Private Limited |
| Prasanta Kumar Maiti DIN 06855565 | Director | 27 Feb 2015 | 11 yrs 7 mo | Imgenex India Private Limited |
People of Imgenex India
1 people are tracked at Imgenex India (1 in leadership); the tracked headcount is 31.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Imgenex India
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Imgenex India
Figures of Imgenex India Private Limited, the primary company behind Imgenex India, for FY 2025. Revenue was ₹4.32 Cr (+8% year on year). Net profit was ₹19.8 Lakh (5% margin). EBITDA was ₹99.6 Lakh (23% margin). Revenue has grown at a compounded annual rate of -15% over three years and +7% over five years.
- ₹4.32 CrRevenue · FY 2025 · +8% YoY
- ₹19.8 LakhNet profit · 5% margin
- ₹99.6 LakhEBITDA · 23% margin
- ₹1.15 CrPaid-up capital
- 31Employees (provident fund records)
- -15%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Imgenex India Private Limited are on its company page.
Detailed financial statements for Imgenex India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Imgenex India
3 dated milestones of Imgenex India across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Imgenex India is founded.
- Funding First funding round of $297K.
- Funding Latest funding round, Grant,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Imgenex India
Imgenex India was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Imgenex India is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
Sujay Singh is the CEO of Imgenex India, as recorded in our data. They have also founded this company.
Imgenex India is a funded company, having raised a total of $297.15K across 3 funding rounds to date. The company's 1st funding round was a Seed of $297.15K, raised on Jan 2007.
Imgenex India has 31 employees.
The primary company behind Imgenex India, Imgenex India Private Limited, reported revenue of ₹4.32 Cr for FY 2025, up 8% year on year.
Imgenex India is an antibody and reagent developing company providing custom services in antibody development, recombinant protein production, and stable cell line development. It is also carrying out research projects in the areas of osteoporosis, cancer, and stem cells and inflammatory diseases either independently or in collaboration with national and international institutions. Its projects include developing a peptide-based therapy for osteoporosis in collaboration with Institute of Life Sciences (ILS), developing high expression plasmid vectors for production of biosimilar Herceptin and other recombinant proteins and bioprocess development for production of biosimilar Trastuzumab in phase II.
Imgenex India offers Therapeutic Antibodies, Stable Cell Lines, Custom Antibody Development, Protein Production, and Drug Discovery Screening.
Imgenex India has 2 investors. Key investors include Department of Biotechnology, and CliniSciences.
The valuation of Imgenex India is $317.62K as of Jan 2007.
Imgenex India operates through Imgenex India Private Limited.
The legal entities of Imgenex India currently have 4 directors, including Gita Singh, Subrat Kumar Kar, Prasanta Kumar Maiti and others.